The US FDA’s EIR is received for the drug-device combination to be commercialised from the Stelis Pharma#39;s flagship facility in Bengaluru, India
The US FDA’s EIR is received for the drug-device combination to be commercialised from the Stelis Pharma#39;s flagship facility in Bengaluru, India The US FDA’s EIR is received for the drug-device combination to be commercialised from the Stelis Pharma#39;s flagship facility in Bengaluru, India Moneycontrol Latest News Read More